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The Hedgehog (Hh) signaling pathway plays critical
roles in metazoan development and in cancer. How
the Hh ligand is secreted and spreads to distant
cells is unclear, given its covalent modification with
a hydrophobic cholesterol molecule, which makes
it stick to membranes. We demonstrate that Hh
ligand secretion from vertebrate cells is accom-
plished via two distinct and synergistic cholesterol-
dependent binding events, mediated by two proteins
that are essential for vertebrate Hh signaling: the
membrane protein Dispatched (Disp) and a member
of the Scube family of secreted proteins. Cholesterol
modification is sufficient for a heterologous protein
to interact with Scube and to be secreted in a
Scube-dependent manner. Disp and Scube recog-
nize different structural aspects of cholesterol simi-
larly to how Niemann-Pick disease proteins 1 and
2 interact with cholesterol, suggesting a hand-off
mechanism for transferring Hh from Disp to Scube.
Thus, Disp and Scube cooperate to dramatically
enhance the secretion and solubility of the choles-
terol-modified Hh ligand.
INTRODUCTION
The Hedgehog (Hh) signaling pathway has fundamental roles in
embryonic development, adult stem cell maintenance, and
carcinogenesis (Lum and Beachy, 2004). Hh signaling is trig-
gered by binding of the secreted Hh ligand to its membrane
receptor, Patched (Ptch), setting in motion signal transduction
events that ultimately lead to the specific transcriptional output
of the Hh pathway. The Hh ligand is generated from a precursor
protein that is translocated into the endoplasmic reticulum (ER),
undergoes signal sequence cleavage, and is then modified
covalently with two lipids: (1) a palmityl residue is attached at
the N terminus by the palmityl transferase Skinny hedgehog
(Chamoun et al., 2001), and (2) a cholesteryl residue is attached
at the C terminus by autocatalytic modification (Porter et al.,
1996). The cholesterol modification reaction relies on the intein
activity of the C-terminal domain of the Hh precursor, and gener-
ates an N-terminal fragment (the cholesterol-modified Hh ligand)308 Cell Reports 2, 308–320, August 30, 2012 ª2012 The Authorsand a C-terminal fragment that is disposed of by ER-associated
degradation (Chen et al., 2011). The two lipid modifications of
the Hh ligand occur independently (Chamoun et al., 2001) and
are both essential for normal Hh signaling (Chamoun et al.,
2001; Traiffort et al., 2004).
The Hh ligand is strongly hydrophobic and hence membrane-
associated, which raises critical questions as to how it is
secreted and how it can reach cells located at a distance from
the signaling cell. Genetic analysis identified Dispatched (Disp)
and the Scube family of proteins as being essential for long-
range Hh signaling. Disp is a multispanning membrane protein
that is required for long-range Hh signaling in Drosophila (Burke
et al., 1999), mouse (Ma et al., 2002), and zebrafish (Nakano
et al., 2004). Disp belongs to the RND family of transporters
(Tseng et al., 1999) and contains a sterol-sensing domain
(SSD), a sequence of five consecutive membrane-spanning
helices found in several membrane proteins that are involved
in cholesterol homeostasis (Kuwabara and Labouesse, 2002).
Disp is specifically required for secretion of cholesterol-modified
Hh, as the N-terminal fragment of Hh without the cholesterol
modification can be released in the absence of Disp. The Scube
family (Grimmond et al., 2000) consists of the secreted proteins
Scube1, Scube2, and Scube3, and is required for long-range Hh
signaling in zebrafish (Johnson et al., 2012). Scube2 was first
identified in zebrafish (Hollway et al., 2006; Kawakami et al.,
2005; Woods and Talbot, 2005) as playing a non-cell-autono-
mous role in long-range Hh signaling. Epistatic analysis led to
the proposal that Scube2 is involved in the transport or stability
of Hh ligand in the extracellular space (Hollway et al., 2006;
Kawakami et al., 2005; Woods and Talbot, 2005).
The mechanism by which the Disp and Scube proteins
promote long-range Hh signaling is unknown. Although Disp is
required for Hh secretion, there is no direct evidence that Disp
participates in Hh release from cells. Additionally, it is unclear
how the Hh ligand is kept soluble in the extracellular space,
and how it is delivered to responding cells. Regarding Scube
proteins, it is unclear whether they are involved in Hh biosyn-
thesis or secretion, or in another aspect of Hh function outside
the producing cell.
Here we dissect the mechanism of Hh secretion in vertebrate
cells. We show that the vertebrate homolog, Dispatched-A
(DispA), interacts with human Sonic hedgehog (hShh) via its
cholesterol anchor, and that this interaction is necessary for
hShh secretion. Of interest, an inactive DispA mutant binds
hShh more strongly than wild-type (WT) DispA, suggesting that
dissociation of hShh from DispA is important for efficient secre-
tion. However, DispA alone is not sufficient to release hShh from
cells, indicating that additional factors are required to overcome
the insolubility conferred by cholesterol modification. We
demonstrate that a Scube family member, Scube2, synergizes
with DispA to cause a dramatic increase in hShh secretion.
Scube2 binds the cholesterol anchor of hShh, and this inter-
action is necessary to promote hShh secretion. Cholesterol
modification is sufficient for a heterologous protein to bind
Scube2 and to be secreted in a Scube2-dependent manner.
Importantly, DispA and Scube2 recognize different aspects of
the cholesterol anchor of hShh. Our results support a model in
which membrane-associated hShh is secreted by being handed
off from DispA to Scube2, in a manner reminiscent of the trans-
port of free cholesterol by the Niemann-Pick disease proteins
NPC1 and NPC2 (Infante et al., 2008b). Thus, a relay mechanism
involving DispA and Scube2 promotes the release of cholesterol-
modified hShh from the plasma membrane of producing cells.
RESULTS
DispA Interacts with hShh in a Cholesterol-Dependent
Manner
It was previously suggested that Disp may bind cholesterol-
modified Hh (Burke et al., 1999); however, such an interaction
has not been demonstrated. We first tested whether mouse
DispA binds cholesterol-modified hShh by coimmunoprecipita-
tion. DispA and hShh were stably coexpressed in 293T cells,
followed by detergent solubilization and immunoprecipitation.
Under these conditions, WT DispA showed modest but repro-
ducible binding to cholesterol-modified hShh (Figure 1A),
consistent with the expectation of a transient DispA-hShh inter-
action. To probe the cholesterol dependence of the interaction,
we expressed a construct that encodes the N-terminal fragment
of hShh (hShhN, amino acids 1–198), which generates a protein
that lacks cholesterol but is still palmitylated (Chamoun et al.,
2001; Chen et al., 2004). DispA did not bind hShhN (Figure 1A),
indicating that binding to hShh is cholesterol dependent. Of
interest, the inactive DispA mutant, DispA-NNN (Ma et al.,
2002), showed significantly stronger hShh binding compared
with WT DispA (Figure 1A), and the same result was obtained
with the inactive mutant, DispA-AAA. DispA-NNN and DispA-
AAA are triple-point mutants in which three aspartate residues
located in transmembrane helices 4 and 10 are mutated to
asparagines or alanines. One of these aspartates is conserved
in RND family proteins and is required for their transporter func-
tion. Our results suggest that DispA-NNN and DispA-AAA are
defective in hShh secretion, perhaps because they bind hShh
too tightly and thus interfere with its release from cells.
A potential problem with our binding assay is that detergent
solubilization could have a negative effect on the native con-
formation of DispA and/or might disrupt the DispA-hShh inter-
action. Therefore, we developed a strategy to examine the
DispA-hShh interaction in intact cells using two different photo-
reactive cholesterol derivatives: (1) 6-azicholestanol (compound
1 in Figure 1B), a photoreactive sterol that carries a diazirine
group on the B ring of the molecule (Thiele et al., 2000), and (2)
25-azicholesterol (compound 2 in Figure 1B), a photoreactivesterol that we synthesized, which carries a diazirine group at
the end of the isooctyl tail. We reasoned that having the photo-
reactive group in two locations of the sterol molecule would
increase our chance of detecting a potential interaction with
DispA. We first asked whether the two photoreactive sterols
modify hShh in cells. When cells stably expressing hShh (Chen
et al., 2011) were depleted of sterols by acute treatment with
methyl-b-cyclodextrin (MCD), hShh processing was strongly
inhibited, causing accumulation of the unprocessed hShh
precursor (Figure 1C). Processing was rescued by adding back
cholesterol (compound 3 in Figure 1B) but not the diastereomer
epicholesterol (compound 4 in Figure 1B), which is inactive in
modifying Hh proteins (Mann and Beachy, 2004). Adding back
either of the two photoreactive sterols fully rescued hShh pro-
cessing (Figure 1C). We next used this strategy to generate
hShh modified with photoreactive sterols by labeling cells that
stably express DispA and hShh. The cells were then UV-irradi-
ated, and the formation of a covalent DispA-hShh bond was
tested by denaturing immunoprecipitation of DispA followed by
immunoblotting for hShh. DispA showed crosslinking to hShh
modified with photoreactive sterol (Figure 1D), but not to hShhN,
demonstrating that DispA binds hShh in a cholesterol-depen-
dent manner in intact cells. Of interest, DispA was photocros-
slinked much more efficiently when hShh was modified with
25-azicholesterol than when it was modified with 6-azicholesta-
nol (Figures 1D and 1F), suggesting that the isooctyl tail of
cholesterol is a feature recognized byDispA during its interaction
with hShh. Consistent with a DispA-hShh interaction in cells,
DispA (both the WT and the NNN mutant) and hShh were
shown to be present at the plasma membrane by immunofluo-
rescence microscopy (Figure 1E). Importantly, not all hShh
puncta colocalize with DispA at the membrane, as expected
from a transient interaction between the two proteins. In contrast
to hShh, hShhN is found predominantly in intracellular vesicles
and not at the plasma membrane (Figure 1E), consistent with
the efficient release of hShhN from the cell surface.
We next asked whether binding of DispA to hShh is important
for hShh secretion. To generate a DispA mutant that cannot bind
hShh, we deleted the first extracellular loop of DispA. This choice
was based on the role that the first extracellular loop plays in two
Disp-related proteins: it is required in the SREBP cleavage-
activating protein (SCAP) for binding cholesterol (Motamed
et al., 2011), and in Ptch for binding hShh (Marigo et al., 1996).
Indeed, DispA-Dloop1 did not bind hShh in our in vivo photo-
crosslinking assay (Figure 1F). We turned to a cellular assay
that relies on the function of DispA in hShh secretion and
long-range signaling. DispA/ mouse embryonic fibroblasts
(MEFs) (Ma et al., 2002) were cocultured with the Hh reporter
cells, Shh Light II (Taipale et al., 2000). Stable expression of
hShh in DispA/ MEFs caused a slight activation of the Hh
pathway in the reporter cells (Figure 1G) because short-range
Hh signaling does not require DispA. Coexpression of mCherry-
tagged DispA in DispA/ MEFs strongly increased the
response of reporter cells, indicating that DispA rescued hShh
secretion (Figure 1G). As expected, DispA did not affect
signaling by DispA/ MEFs expressing hShhN (Figure 1G),
because DispA is only required for secretion of cholesterol-
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DispA in NIH 3T3 cells (Figure S1). In contrast to WT DispA,
mCherry-tagged DispA-Dloop1 or DispA-NNN did not rescue
signaling by DispA/ MEFs expressing hShh, a result that is
more obvious at a lower ratio of signaling cells to reporter cells
(Figure 1H). The fact that DispA-Dloop1 is inactive suggests
that cholesterol-dependent binding of hShh to DispA is required
for hShh secretion.
DispA Is Not Sufficient to Release Cholesterol-Modified
hShh from Cells
Although the coculture system provides a good functional assay
for DispA, it measures hShh secretion only indirectly. To test
directly whether DispA is sufficient for hShh release from
membranes, we examined secretion of hShh from 293T cells
that stably overexpress DispA. Because we observed that serum
releases hShh in a nonspecific, DispA-independent manner, we
took care to remove residual serum from the cells by repeated
washes with serum-free medium. Under serum-free conditions,
no hShh was released into the medium, in the absence or pres-
ence of overexpressed DispA, as assayed by western blotting
(Figure 2A) or by Hh activity assays (Figure 2B). These cells ex-
pressed large amounts of hShh, which was properly processed
(Figure 2A) and strongly localized to the plasma membrane as
determined by immunofluorescence microscopy. In contrast,
stably expressed hShhN was efficiently secreted into serum-
free medium and was active. As expected, DispA had no effect
on hShhN secretion (Figures 2A and 2B). These results indicate
that DispA alone is not sufficient to release hShh, perhaps
because another factor is required to solubilize it in the media,
and in the absence of such a factor, hShh remains membrane-
associated.
Cholesterol Is the Main Determinant of hShh Membrane
Association
Given that hShhN is efficiently secreted, we tested whether the
cholesterol anchor is responsible for the strong association ofFigure 1. Cholesterol-Dependent Binding of hShh to DispA Is Required
(A) 293T cells stably coexpressing hShh or hShhN, and myc-tagged WT DispA
noprecipitation with anti-myc antibodies, followed by SDS-PAGE and immunobl
(B) Structures of the photoreactive sterols 6-azicholestanol (1) and 25-azichole
diastereomer, epicholesterol (4).
(C) HShh, HA-tagged at the C terminus (hShh-HA) was stably expressed in 293T
epicholesterol (epiChol), 6-azicholestanol (6-azi), or 25-azicholesterol (25-azi) wa
SDS-PAGE and immunoblotting with HA antibodies (to detect the hShh precur
hShh ligand).
(D) 293T cells stably coexpressing myc-tagged DispA-WT and hShh or hShhN we
were UV-irradiated, and DispA-hShh photocrosslinking was analyzed by denat
immunoblotting for hShh. Immunoblotting for tubulin served as the loading contr
(E) Left panels: Immunofluorescencemicroscopy of hShh stably coexpressedwith
rabbit anti-hShh and mouse anti-myc antibodies, followed by goat anti-rabbit A
Localization by immunofluorescence microscopy of hShh and hShhN expressed
(F) As in (C) but with 293T cells stably coexpressing myc-tagged DispA or the mut
hShhN.
(G) DispA/ MEFs stably expressing hShh or hShhN, rescued by lentiviral exp
Shh Light II cells at a 1:20 ratio. Luciferase measurements were normalized to rep
Error bars represent the SD of the mean.
(H) DispA/MEFs stably expressing hShh, transduced with lentiviruses expres
as in (G), at four different ratios of hShh-producing cells to reporter cells.
See also Figure S1.hShh with membranes. HShh was quickly released from cells
when media were supplemented with MCD (Figure 2C), which
can be explained by MCD binding the cholesterol anchor and
promoting hShh solubilization. In contrast to hShh, secretion of
hShhN was not further enhanced by MCD (Figure 2C).
We next asked whether the other hydrophobic modification of
hShh, palmitylation, plays a role in hShh’s association with
membranes. Like WT hShh, hShh-C24S, a mutant of hShh that
cannot be palmitylated but is still modified with cholesterol
(Chamoun et al., 2001), was membrane-associated and was
not secreted into serum-free medium (Figure 2D). As expected,
hShhN and hShhN-C24S, a mutant that lacks both the choles-
teryl and palmityl moieties, were efficiently secreted (Figure 2D).
Finally, we asked whether cholesterol modification of an
unrelated soluble protein is sufficient to recapitulate the strong
membrane attachment of hShh. We used a construct encoding
a secreted version of the Halotag protein fused to the
C-terminal domain of hShh (Halotag-Chh). In cells, this fusion
undergoes autocatalytic processing to generate cholesterol-
modified Halotag. Hemagglutinin (HA)-tagged Halotag-Chh
was expressed in 293T cells, and secretion into serum-free
medium was measured by immunoblotting with HA antibodies.
Under these conditions, cholesterol-modified Halotag was not
secreted and remained membrane-associated (Figure 2E); in
contrast, Halotag without the cholesterol modification was
soluble (Figure 2E).
Together, these results indicate that the cholesterol anchor
is necessary and sufficient for hShh membrane attachment,
and the palmityl moiety plays a less important role, if any.
Thus, in order to secrete hShh, cells must find a way to solubilize
its cholesterol anchor.
Scube2 Dramatically Increases Secretion of
Cholesterol-Modified hShh
The experiments described above suggest the existence of
an extracellular protein that helps the secretion of hShh byfor hShh Secretion
(WT) or DispA-NNN (NNN) were lysed with detergent and analyzed by immu-
otting with anti-hShh antibodies.
sterol (2). Also shown are the structures of cholesterol (3) and the inactive
cells. The cells were sterol-depleted with MCD, after which cholesterol (Chol),
s added back as a soluble MCD complex for 3 hr. Lysates were analyzed by
sor and the C-terminal fragment, hShhC) and hShh antibodies (to detect the
re labeled with the indicated sterols, as in (B). After incubation for 6 hr, the cells
uring immunoprecipitation with myc antibodies, followed by SDS-PAGE and
ol.
myc-tagged DispA-WT or DispA-NNN in NIH 3T3 cells. Cells were stained with
lexa488 and goat anti-mouse Alexa594 secondary antibodies. Right panels:
in DispA/ MEFs.
ant missing the first extracellular loop, DispA-Dloop1 (D), together with hShh or
ression of mCherry-tagged DispA or not, were cocultured with Hh-responsive
orter cells grown alone (control). All experiments were performed in triplicate.
sing mCherry-tagged DispA-WT, DispA-Dloop1, or DispA-NNN were analyzed
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Figure 2. DispA Is Not Sufficient for Release
of Cholesterol-Modified hShh
(A) 293T cells stably expressing hShh and myc-
tagged DispA constructs were washed of serum
and incubated with serum-free media for 6 hr.
Secreted proteins were precipitated with TCA.
Pellet and supernatant fractions were analyzed by
SDS-PAGE and immunoblotting with anti-myc and
anti-hShh antibodies. Blotting for GSK3 served as
the loading control.
(B) Supernatants collected as in (A) were diluted
1:2 with serum-free media and hShh activity
was assayed using Shh Light II reporter cells.
Measurements were performed in triplicate and
error bars represent the SD of the mean.
(C) 293T cells expressing hShhN or hShh were
incubated with serum-free media, with or without
MCD (100 mM), and supernatants were harvested
after 1 or 3 hr. Secretion of hShh and hShhN
was analyzed as in (A).
(D) 293T cells transiently expressing hShh, hShhN,
or hShh with a palmitylation site mutation (hShh-
C24S), or hShhN with a palmitylation site muta-
tion (hShhN-C24S) were incubated in serum-free
media for 4 hr, and secreted proteins were
precipitated with TCA. Pellet and supernatant
fractions were analyzed as in (A). The samples in
this panel were loaded in duplicate.
(E) A secreted HA-tagged Halotag protein was
fused to amino acids 190-462 of hShh (Halo-Chh).
Autocatalytic processing of Halo-Chh generated
Halotag fused to amino acids 190–198 of hShh,
modified with cholesterol. Secreted HA-Halotag
fused to amino acids 190–198 of hShh (Halo) was
not cholesterol-modified and served as the negative control. The Halotag constructs were expressed in 293T cells, and secreted proteins were collected into
serum-free media for 4 hr. Pellet and supernatant fractions were analyzed by SDS-PAGE and immunoblotting with anti-HA antibodies.overcoming its cholesterol-dependent insolubility. The Scube
family of secreted proteins is required for long-range Hh
signaling in zebrafish (Johnson et al., 2012), but its mechanism
is unknown. We examined whether the first Scube protein
implicated in Hh signaling, Scube2 (Hollway et al., 2006; Kawa-
kami et al., 2005; Woods and Talbot, 2005), is involved in
releasing hShh from cells. When Scube2 was expressed in
293T cells stably expressing hShh, it caused a dramatic
increase in secretion of active hShh (Figure 3A). As a negative
control, we used Scube2DCUB, a truncation mutant of Scube2
that lacks a C-terminal portion of the protein, including
a cysteine-rich domain and a CUB domain. This loss-of-func-
tion mutation was identified in the initial cloning of zebrafish
Scube2 (Woods and Talbot, 2005). Scube2DCUB was effi-
ciently secreted but failed to stimulate hShh secretion (Fig-
ure 3A). Scube2 supplied exogenously also released hShh
into serum-free media, indicating that Scube2 and hShh do
not have to be coexpressed (Figure 3B). Scube2 had no effect
on the secretion of hShhN, indicating that it acts specifically to
release cholesterol-modified hShh (Figure 3C). Of interest,
although the amount of released hShh was significantly smaller
than that of hShhN, the signaling activity of hShh was much
higher than that of hShhN (Figure 3C), suggesting that choles-
terol modification greatly enhances the potency of the hShh
ligand.312 Cell Reports 2, 308–320, August 30, 2012 ª2012 The AuthorsIt is known that hShh can be released from cells by serum
(Chen et al., 2011) and by high levels of heparin. HShh released
with either serum or heparin was inactive in signaling assays, in
contrast to hShh released by Scube2 (Figure S2). Thus, unlike
other factors that can release hShh, release by Scube2 is
physiological.
All Scube2 orthologs contain a conserved hydrophobic
stretch in the middle of the CUB domain (Figure 3D), whereas
the rest of the protein shows little clustering of hydrophobic
amino acids outside the signal sequence. We reasoned that
this hydrophobic stretch might be important for release of
hShh. Indeed, a Scube2 mutant in which eight amino acid resi-
dues in the hydrophobic stretch are mutated to alanines
(Scube2-8Ala) is secreted (Figure 3E) but is completely inactive
in releasing hShh (Figures 3E and 3F). This indicates that the
conserved hydrophobic sequence in the CUB domain is neces-
sary for Scube2 activity.
We next asked whether palmitylation of hShh is required for
release by Scube2. Like WT hShh, the nonpalmitylated mutant
hShh-C24S was released by Scube2 but not by Scube2DCUB
(Figure 3G), indicating that palmitylation is not required for
Scube-mediated hShh secretion. The Scube2-released hShh-
C24S was inactive in Hh signaling assays (Figure 3H), consistent
with the requirement of the palmityl modification for Hh activity
(Chamoun et al., 2001).
We also performed an experiment to determine the effect of
temperature on the release of hShh from cells by Scube2.
Although the added Scube2 released a significant amount of
hShh during 1 hr at 37C, no hShhwas released at 4C (Figure 3I).
This is consistent with Scube2 having to overcome the hydro-
phobic interaction between the cholesterol anchor of hShh and
the membrane, an interaction of increased strength at lower
temperature.
Scube2 Does Not Affect hShh Processing in Producing
Cells or Signaling in Responding Cells
One possible explanation for the enhanced secretion of hShh is
that Scube2 stimulates hShh processing in producing cells. A
radioactive pulse-chase analysis of hShh processing showed
that it proceeded with the same kinetics in the presence of
coexpressed Scube2 or the inactive Scube2DCUB mutant
(Figure 4A). This result indicates that Scube2 does not affect
hShh processing.
To determine whether Scube2 has an effect on Hh signal
transduction, we performed two experiments. First, we asked
whether Scube2 affects signaling by hShhN. Increasing concen-
trations of Scube2 added to a fixed concentration of hShhN
had no effect on Hh pathway stimulation (Figure 4B, left side of
the graph). In a second experiment, we asked whether excess
Scube2 affects signaling by hShh. When increasing amounts of
Scube2 were added to hShh released into Scube2-containing
media, therewas no effect on Hh pathway stimulation (Figure 4B,
right side of the graph); furthermore, Scube2 had no effect on
Hh signaling on its own. Although it was previously proposed
that Scube2 promotes Hh signaling at the level of the responding
cell, possibly via its interaction with Ptch (Tsai et al., 2009), our
Scube2 titration experiment argues against such a model. Our
data, however, cannot exclude the possibility that the hShh-
Scube2 complex (see below) is the active species in long-range
Hh signaling.
Scube2 Binds hShh in a Cholesterol-Dependent Manner
It seemed likely that Scube2 might stimulate hShh secretion
by direct binding. We first tested this hypothesis by immuno-
precipitation of hShh secreted into serum-free medium by
cells coexpressing hShh and HA-tagged Scube2, followed by
immunoblotting for HA. Under these conditions, we detected
binding of Scube2 to hShh (Figure 4C). Scube2 did not bind
hShhN, indicating that Scube2 binds hShh in a cholesterol-
dependent manner (Figure 4C). As expected, the inactivemutant
Scube2DCUB did not release or bind hShh, suggesting that
binding to Scube2 is required for hShh secretion.
In the above experiment, hShh was immunoprecipitated with
the 5E1 monoclonal antibody, which blocks binding of hShh
to Ptch and to the antagonist Hedgehog-interacting protein
(HIP), due to the very similar binding interfaces between hShh
and 5E1, HIP, and Ptch (Maun et al., 2010). In contrast, the
5E1 antibody did not block binding of hShh to Scube2, indicat-
ing that the hShh-Scube2 interface is distinct, and thus hShh
binding to Scube2 might allow hShh interaction with the down-
stream components Ptch and HIP.
Finally, we examined the interaction between Scube2 and
hShh in cells by photocrosslinking. Cells stably expressingHA-tagged Scube2 and hShh were labeled with photoreactive
sterols and then UV-irradiated. Lysates were subjected to
denaturing immunoprecipitation with HA antibodies, followed
by immunoblotting for hShh. We detected crosslinking between
hShh modified with 6-azicholestanol and Scube2; as expected,
Scube2DCUB was not crosslinked to Scube2 (Figure 4D).
Interestingly, hShh modified with 25-azicholesterol showed
much less crosslinking to Scube2 (Figure 4D), in contrast to
DispA-hShh crosslinking, which occurred preferentially with
25-azicholesterol. This differential crosslinking suggests that
Scube2 and DispA recognize different structural aspects of the
cholesterol molecule, in a manner that might facilitate the
hand-off of hShh from DispA to Scube2.
DispA Synergizes with Scube2 to Promote hShh
Secretion
We next tested whether DispA and Scube2 act synergistically
to promote hShh secretion, first in the coculture system of
DispA/MEFs andHh reporter cells. DispA/MEFs express-
inghShhandDispAwereplatedat different ratioswithHh reporter
cells, and the cocultures were incubated with Scube2 in serum-
free media, followed by Hh activity assays. Under these condi-
tions, Scube2 strongly synergized with WT DispA to cause hShh
secretion and Hh pathway activation (Figure 5A). As expected,
Scube2 did not synergize with DispA-NNN and had no effect on
signaling by hShhN; also, Scube2DCUB had no effect on hShh
(Figure 5A). Interestingly, at a higher ratio of hShh-producing cells
to reporter cells, Scube2 was able to release some hShh even in
theabsenceofDispA (Figure5A), consistentwithamodel inwhich
hShhpartitions between themembraneandScube2 in themedia.
Similar results were obtained when we measured hShh
secretion in 293T cells in the absence and presence of coex-
pressed myc-tagged DispA. Addition of Scube2 to the cells
synergized with WT DispA to release hShh into the supernatant,
as assayed by immunoblotting (Figure 5B). As expected, Scube2
did not synergize with DispA-NNN, and Scube2DCUB had no
effect on hShh secretion, irrespective of the presence of DispA
(Figure 5B). Similarly, Scube2 added to 293T cells synergized
with DispA (but not with DispA-Dloop1) to cause secretion of
hShh, as measured by Hh reporter assays (Figure 5C). Together,
these data show that DispA and Scube2 act synergistically to
promote hShh secretion.
Cholesterol Modification Is Sufficient for Interaction
with Scube2 and Scube2-Dependent Secretion
We sought to determine whether cholesterol modification is
sufficient for interaction with Scube2, by photocrosslinking
in vitro. To that end, we used an unrelated protein [maltose-
binding protein (MBP)] that we modified with photoreactive
sterols by in vitro processing (Chen et al., 2011; Figure 6A). We
then incubated sterol-modified MBP fusions with HA-tagged
Scube2, followed by UV irradiation and immunoblotting with
HA antibodies, to detect an increase in Scube2 size due to
photocrosslinking. Under these conditions, Scube2 was cross-
linked to MBP modified with 6-azicholestanol (Figure 6B), and
much less efficiently to MBP modified with 25-azicholesterol.
This is the same preference for 6-azicholestanol over 25-azicho-
lesterol that we observed for hShh-Scube2 photocrosslinking inCell Reports 2, 308–320, August 30, 2012 ª2012 The Authors 313
Figure 3. The Extracellular Protein Scube2 Stimulates Secretion of Cholesterol-Modified hShh
(A) Scube2 or Scube2DCUB was transfected into 293T cells stably expressing hShh, and 24 hr later secreted proteins were collected into serum-free media for
4 hr. HShh activity in serial dilutions of the supernatant wasmeasured by luciferase assay in Shh Light II reporter cells. All experimentswere performed in triplicate.
Error bars represent the SD of the mean.
(B) Scube2 or Scube2DCUB was added in serum-free media to 293T cells stably expressing hShh, for 4 hr. Activity of secreted hShh was measured as in (A).
(C) As in (A) but with 293T cells stably expressing hShh or hShhN. Secreted hShh and hShhN were collected for 6 hr and analyzed by reporter assay in Shh Light II
cells and by immunoblotting with anti-hShh antibodies. Note the much higher amount of secreted hShhN compared with hShh.
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Figure 4. Cholesterol-Dependent Binding
of Scube2 to hShh Is Required for hShh
Secretion
(A) HA-tagged Scube2 or Scube2DCUB was
expressed in 293T cells stably expressing hShh.
The cells were pulsed with 35S-methionine for
3min and chasedwith media containing unlabeled
methionine for the indicated times. HShh pro-
cessing was analyzed by immunoprecipitation
with the 5E1 antibody, which recognizes full-
length and processed hShh. Scube2 and Scu-
be2DCUB were immunoprecipitated with anti-HA
antibodies. The precipitated protein was analyzed
by SDS-PAGE and fluorography. The same
number of cells was processed for each condition.
(B) The two graphs on the left show that Scube2
does not affect hShhN activity. hShhN was mixed
with HA-tagged Scube2 or Scube2DCUB, at the
indicated ratios, and its activity was measured in
Shh Light II reporter cells. The two graphs on
the right show that Scube2 does not affect the
activity of hShh prereleased with Scube2. 293T
cells coexpressing hShh and HA-tagged Scube2
were used to generate serum-free hShh-Scube2
conditioned media. This media was mixed with
HA-tagged Scube2 or Scube2DCUB, at the indicated ratios, and its activity was measured in Shh Light II reporter cells. All experiments were performed in
triplicate. Error bars represent the SD of the mean.
(C) 293T cells coexpressing hShh or hShhN, and HA-tagged Scube2 or Scube2DCUB were incubated in serum-free media for 4 hr. HShh and hShhN were
immunoprecipitated from the supernatant with 5E1 antibodies. A portion of the supernatant was TCA-precipitated to serve as input. All samples were analyzed
by SDS-PAGE and immunoblotting with anti-HA and anti-hShh antibodies.
(D) HShh or hShhN was stably coexpressed with HA-tagged Scube2 or Scube2DCUB in 293T cells. The cells were labeled with the indicated sterols, followed
by UV irradiation. Photocrosslinked Scube2-hShh was analyzed by denaturing immunoprecipitation with HA antibodies, followed by SDS-PAGE and
immunoblotting for hShh.cells (Figure 4D). The size of the electrophoretic mobility shift
in Scube2 crosslinked to MBP (Figure 6B) is consistent with
the addition of one molecule of MBP (40 kDa), indicating a 1:1
binding ratio between Scube2 and sterol-modified MBP. As
expected, Scube2DCUB was not crosslinked to any of the
sterol-modified MBP proteins. These results suggest that
cholesterol modification is sufficient for binding to Scube2.
Finally, we investigated whether cholesterol modification is
sufficient for Scube2-dependent secretion. For this purpose,
we used cholesterol-modified Halotag, which is membrane-
associated (Figure 2E). HA-tagged Halotag-Chh was coex-
pressed in 293T cells with myc-tagged Scube2, and secretion
into serum-free medium was measured by immunoblotting. As
shown in Figure 6C, cholesterol-modified Halotag was secreted
only in the presence of Scube2, whereas Halotag without
a cholesterol anchor was secreted independently of Scube2.(D) Sequence of the conserved hydrophobic patch in the CUB domain of vertebrat
which eight hydrophobic residues are mutated to alanines.
(E) HA-tagged Scube2, Scube2-8Ala, or Scube2DCUB was transfected into 29
collected for 6 hr into serum-free media. Aliquots of the cell pellet and supernata
(F) HShh activity in the supernatants collected in (E) was measured as in (A).
(G) HShh or the palmitylation-defective mutant hShh-C24S were coexpressed in
secretion was analyzed as in (E).
(H) HShh and hShh-C24S activity in the supernatants collected in (G) was measu
(I) Scube2 or Scube2DCUBwas added in serum-free medium to 293T cells stably
measured as in (A).
See also Figure S2.As expected, Scube2DCUBdid not release cholesterol-modified
Halotag. These data demonstrate that a cholesterol anchor
is sufficient for an unrelated soluble protein to become
membrane-associated, to bind Scube2, and to be secreted in
a Scube2-dependent manner.
DISCUSSION
This study suggests a mechanism whereby hShh is released
from cells in spite of its strong association with membranes.
HShh has two lipid modifications: a palmityl residue at the
N terminus and a cholesteryl residue at the C terminus. The
cholesteryl moiety is mainly responsible for the insolubility of
hShh, which has to be overcome to allow hShh mobilization
and long-range Hh signaling. We now show that the multispan-
ning membrane protein DispA and the secreted protein Scube2e Scube2 orthologs. Also shown is the sequence of the Scube2-8Alamutant, in
3T cells stably expressing hShh, and 24 hr later the secreted proteins were
nts were analyzed by SDS-PAGE and immunoblotting for HA and hShh.
293T cells with HA-tagged Scube2 or Scube2DCUB. HShh and hShh-C24S
red as in (A).
expressing hShh, for 1 hr at 37C or 4C. HShh activity in the supernatants was
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Figure 5. Scube2 Synergizes with DispA to Stimulate Secretion of
Cholesterol-Modified hShh
(A) DispA/ MEFs stably expressing hShh, transduced with lentiviruses
expressing mCherry-tagged WT DispA or DispNNN, were plated with Shh
Light II reporter cells at 1:40 and 1:80 ratios. After 12 hr, Scube2 or Scu-
be2DCUB was added in serum-free media. Luciferase measurements were
performed 30 hr later and normalized to untreated reporter cells. All experi-
ments were done in triplicate. Error bars represent the SD of the mean.
(B) HA-tagged Scube2 or Scube2DCUB was transfected into 293T cells
that stably express hShh, hShh, and myc-tagged DispA-WT, or hShh and
myc-tagged DispA-NNN. Secreted proteins were collected 24 hr later into
serum-free media for 4 hr. Aliquots of the cellular pellets and supernatants
were analyzed by SDS-PAGE and immunoblotting with HA, myc, and hShh
antibodies. Blotting for GSK3 served as loading control.
(C) As in (B), but with 293T cells expressing DispA-Dloop1 instead of DispA-
NNN. Activity of secreted hShh was measured as in (A).
Figure 6. Cholesterol Modification Is Sufficient for Interaction with
and Secretion by Scube2
(A) Purified MBP fused to amino acids 244–471 of Drosophila Hh (MBP-DHh)
was used in in vitro processing reactions to generate MBPmodified with either
cholesterol (control), 6-azicholestanol, or 25-azicholesterol. The samples were
analyzed by SDS-PAGE and Coomassie staining. MBP-DHhN and DHh-C are
the two fragments generated by in vitro processing.
(B) The processing reactions in (A) were incubated with HA-tagged Scube2 or
Scube2DCUB, followed by UV irradiation to induce photocrosslinking. The
samples were analyzed by reducing SDS-PAGE and immunoblotting with
HA antibodies. The arrow indicates the position of the photocrosslinked
Scube2-MBP species.
(C) Constructs that generate Halotag protein modified with cholesterol
(Halotag-Chh) or not (Halotag) were coexpressed in 293T cells with myc-
tagged Scube or Scube2DCUB. Secreted proteins were collected in serum-
free media for 6 hr, followed by TCA precipitation and immunoblotting with
HA and myc antibodies.cooperate to accomplish hShh secretion. We demonstrate that
during secretion, hShh uses its unique cholesterol modification
to interact with DispA and Scube2 via two distinct and syner-
gistic binding events, and that these two interactions are
required for hShh secretion. Interestingly, DispA and Scube2
recognize different structural aspects of the cholesterol mole-
cule (Figure 7A), suggesting a hand-off mechanism for trans-
ferring hShh from DispA to Scube2. The advantage of such
a mechanism is that it ensures that hShh is never free in the
aqueous environment, thus preventing its precipitation. Accord-
ing to this model, DispA would act in the hShh-synthesizing cell,
whereas Scube2 could be provided either by the producing cell
or by another cell.
Our results are in agreement with previous genetic evidence
that showed that long-range Hh signaling absolutely requires316 Cell Reports 2, 308–320, August 30, 2012 ª2012 The AuthorsDisp in vertebrates (Ma et al., 2002; Nakano et al., 2004) and
in insects (Burke et al., 1999), and the Scube family of secreted
proteins in zebrafish (Hollway et al., 2006; Johnson et al., 2012;
Kawakami et al., 2005; Woods and Talbot, 2005). Both
Disp and Scube are not required for short-range Hh signal-
ing, consistent with their demonstrated role in hShh secre-
tion rather than signal transduction. In addition, consistent
with our results, a genetic analysis showed that Scube2 acts
Figure 7. Mechanism of hShh Secretion by
DispA and Scube2
(A) Summary of the results for photocrosslinking of
hShh to DispA and to Scube2 in cells. DispA is
crosslinked to hShh modified with 25-azicholes-
terol, and Scube2 is crosslinked to hShh modified
with 6-azicholestanol, suggesting that DispA
and Scube2 recognize different aspects of the
cholesterol molecule.
(B) The hShh ligand associates with membranes
due to its hydrophobic cholesterol anchor. HShh
binds DispA in a cholesterol-dependent manner,
and this interaction is required for hShh secretion,
perhaps by lowering the activation energy for
hShh extraction from the lipid bilayer. From DispA,
hShh is transferred to the secreted protein
Scube2. The fact that DispA and Scube2 recog-
nize different features of the cholesterol molecule
suggests a hand-off mechanism for this transfer,
such that the cholesterol anchor of hShh never
contacts the aqueous environment directly and is
thus kept soluble. This mechanism is reminiscent
of the transfer of free cholesterol between the
Niemann-Pick disease proteins NPC1 and NPC2
during cholesterol egress from late endosomes/
lysosomes.non-cell-autonomously, in contrast to Disp. So far, an essential
role for Scube proteins in Hh signaling has only been demon-
strated in zebrafish (Johnson et al., 2012), but sequence
conservation suggests that the function of Scube is conserved
in mammalian Hh signaling.
While this manuscript was under review, Creanga et al. (2012)
published a study that showed that Scube2mediates the release
of cholesterol- and palmityl-modified hShh. Both that study and
ours agree that cholesterol (but not palmitate) is strictly required
for hShh release by Scube2; however, Creanga et al. showed
that palmitylation enhances the release of hShh by Scube2,
which we did not observe in our experiments. The reason for
this discrepancy remains to be elucidated. It should be pointed
out that Scube-released hShh that lacks the palmitate modifica-
tion is completely inactive in signaling assays (Creanga et al.,
2012 and this study).
Our data support the following sequence of events in hShh
biosynthesis (Figure 7B): Following autocatalytic cholesterol
modification in the ER and palmitylation, hShh reaches the
plasma membrane, to which it remains strongly attached via
its cholesterol anchor. HShh then binds DispA, a cholesterol-
dependent interaction that lowers the activation energy required
for hShh extraction from the bilayer. Alternatively, hShh could
associate with DispA earlier in the secretory pathway, and the
two proteins could travel together to the plasma membrane.
Binding to DispA is necessary but not sufficient for hShh secre-Cell Reports 2, 308–320tion, because an extracellular binding
partner is needed for hShh solubility.
Additionally, if DispA binding is too
strong, hShh secretion is impaired, as
seen with some inactive DispA mutants.
In the next step, hShh is transferredfrom DispA to the secreted protein Scube2, which is required
for long-range Hh signaling in zebrafish. Scube2 interacts with
the cholesterol anchor of hShh and dramatically enhances
hShh secretion by promoting its solubility. Cholesterol modifica-
tion is sufficient, as demonstrated by the fact that an unrelated
protein can be secreted in a Scube2-dependent manner.
Although it is possible that Scube and Shh associate before
reaching the plasma membrane when synthesized in the same
cell, it is clear that this is not required for hShh secretion, as
exogenous Scube2 can release hShh displayed on the cell
surface.
It should be emphasized that the steps in hShh secretion
outlined above represent partitioning equilibria of cholesterol-
modified hShh, so that high concentrations of Scube2 solubilize
hShh from membranes even without DispA (the equilibrium on
the left of Figure 7B). HShh secretion, however, is greatly
enhanced by DispA, as demonstrated by the strong synergy
we observed between DispA and Scube2. How DispA syner-
gizes with Scube2 remains to be elucidated. One possibility is
that the orientation of the cholesterol anchor of hShh in the
membrane favors its transfer to DispA, and is less favorable for
a direct transfer to Scube2. Alternatively, Scube2 might bind
DispA, which could facilitate the transfer of hShh between the
two proteins. Based on homology to RND transporters, it was
postulated that DispA acts as a pump (Ma et al., 2002). We
speculate that the pumping activity of DispA might be involved, August 30, 2012 ª2012 The Authors 317
in the transfer of hShh to Scube2. It will be important to elucidate
the source of energy that DispA uses to pump hShh.
The interaction between Scube2 and hShh is expected to be
dynamic, to allow hShh release. Such a transient interaction
raises the question of how Scube2 keeps hShh soluble. One
model is that hShh is kept soluble by an excess of Scube2,
similar to sterol solubilization by complexation with MCD, in
which sterol-MCD binding is dynamic and a several-fold molar
excess of MCD is usually required for keeping the sterol soluble
in aqueous solution. In amore complicatedmodel, Scube2might
chaperone hShh and help it form a soluble multimeric species in
which the cholesterol anchors are shielded from the aqueous
environment by interactions between hShh monomers. A more
detailed biochemical and structural analysis of the hShh-Scube
interaction will be needed to answer this question.
Our results suggest that Scube2 is not simply a solubilizing
factor. HShh can be released by other agents, such as heparin
and serum, but this requires very high concentrations and the
released hShh is inactive in signaling assays. Thus, Scube2 inter-
acts with hShh in a specific and efficient manner that maintains
hShh activity. This raises the possibility that the hShh-Scube
complex is the active species that signals to responding cells.
For example, Scube2 might interact with Ptch, a possibility sug-
gested by our finding that the 5E1 antibody, which blocks hShh
binding to Ptch, does not block hShh binding to Scube2. Alterna-
tively, Scube2 might interact with one of the hShh coreceptors
Gas1, Cdo, and Boc. Any such interaction could facilitate the
delivery of hShh to responding cells.
Although cholesterol modification of Hh and the role of Disp
are conserved between invertebrates and vertebrates, Scube
proteins are only present in vertebrates. How then do inverte-
brates secrete Hh? A likely possibility is that the role of Scube
is fulfilled in invertebrates by another secreted protein or by
lipoprotein particles. Lipoproteins have been implicated in
systemic transport of Hh in Drosophila (Pana´kova´ et al., 2005).
It is unclear, however, whether lipoproteins are present in the
extracellular space of early embryonic tissues, and thus whether
they play a role in Hh signaling at that stage. A biochemical
approach will be required to determine whether a secreted
protein and/or lipoproteins function in invertebrates in a manner
similar to that observed for Scube in vertebrates.
The proposed mechanism of hShh secretion is reminiscent
of cholesterol trafficking by the Niemann-Pick disease proteins
NPC1 and NPC2 (Infante et al., 2008b), which are involved in
the egress of cholesterol from late endosomes/lysosomes.
Cholesteryl esters are hydrolyzed in the lumen of the lysosome,
releasing free cholesterol that binds NPC2, a soluble luminal
cholesterol-binding protein. NPC2 transfers cholesterol to
NPC1, a multispanning membrane protein in the limiting mem-
brane of the lysosome. Cholesterol is then released from NPC1
into the lysosomal membrane, followed by its transport to other
cellular membranes, perhaps through the cytosolic face of the
membrane.
A comparison of hShh secretion with cholesterol egress from
lysosomes reveals similarities as well as some important
differences. DispA and NPC1 are both members of the RND
family of transporters, and DispA binds the cholesterol anchor
of hShh as NPC1 binds cholesterol (Infante et al., 2008a).318 Cell Reports 2, 308–320, August 30, 2012 ª2012 The AuthorsAlthough there is no homology between Scube2 and NPC2,
they localize to topologically equivalent spaces (the extracellular
space for Scube2 and the lumen of the late endosome/lysosome
for NPC2), and Scube2 binds the cholesterol anchor of hShh
as NPC2 binds cholesterol (Infante et al., 2008b). Importantly,
DispA and Scube2 recognize different aspects of the cholesterol
molecule (Figure 7A), which parallels the two distinct binding
modes of NPC1 and NPC2 to cholesterol (Kwon et al., 2009).
However, whereas DispA appears to recognize the isooctyl tail
of cholesterol, NPC1 binds cholesterol with the 3b-hydroxy
buried and the isooctyl tail exposed (Kwon et al., 2009). Also,
Scube2 appears to not bind the isooctyl tail of cholesterol,
whereas NPC2 binds the isooctyl tail (Kwon et al., 2009). Finally,
one important difference is the direction of transport: DispA
and Scube2 move hShh from the membrane to the extracellular
space, whereas NPC1 and NPC2 transport cholesterol in
reverse, from the lumen of the lysosome into the limiting
membrane.
In summary, our results demonstrate a mechanism for hShh
secretion that is reminiscent of the egress of free cholesterol
from late endosomes/lysosomes. Both processes rely on the
recognition of unique aspects of the cholesterol molecule, and
in both cases a similar mechanism is used to achieve solubility
of the hydrophobic ligand. Because mutations in NPC proteins
cause disease, it seems possible that Disp and Scube could
be involved in the pathogenesis of Hh signaling defects, such
as those that cause holoprosencephaly.EXPERIMENTAL PROCEDURES
Chemicals
The synthesis of the two photoreactive sterols used in this study is described in
the Supplemental Information.
Cell Culture
Details of the cell culture conditions, DNA constructs, immunofluorescence
microscopy, pulse-chase assays, immunoprecipitation, and production of
Scube2-conditioned media are provided in the Supplemental Information.
To determine whether photoreactive sterols modify hShh in vivo, 293T cells
stably expressing hShh-HA (Chen et al., 2011) were sterol-depleted with 1%
MCD in Dulbecco’s modified Eagle’s medium (DMEM) for 45 min. Sterols
were then added back as soluble MCD complexes. After 3 hr, the cells were
harvested and hShh processing was assayed by immunoblotting.
Photocrosslinking in Cells
Human 293T cells stably expressing myc-tagged DispA and hShh constructs
were sterol-depleted, followed by incubation with sterol-MCD complexes
(75 mM for cholesterol and 25-azicholesterol, and 25 mM for 6-azicholestanol)
in OptiMEM (Invitrogen) for 2 hr. After washing with OptiMEM, the cells were
incubated for 6 hr, followed by UV irradiation for 10 min on ice. The
cells were harvested and DispA constructs were subjected to denaturing
immunoprecipitation with anti-myc antibodies (9E10) followed by SDS-PAGE
and immunoblotting with rabbit anti-hShhN antibodies (Cell Signaling). A
similar protocol was used to detect interaction of hShh to HA-tagged Scube2
in cells.
Photocrosslinking In Vitro
A fragment of Drosophila Hh comprising amino acids 244–471 was expressed
and purified from bacteria as a soluble MBP fusion (Chen et al., 2011) and
used to generate photoreactive sterol-modified MBP by in vitro processing.
Sterol-modified MBP was incubated for 1 hr with HA-tagged Scube2 or
Scube2DCUB, followed by UV irradiation for 10 min on ice. The samples were
analyzed by SDS-PAGE and immunoblotting with HA antibodies.
Secretion Assays
293T cells stably expressing hShh were washed several times with DMEM to
remove serum, and incubated in DMEM with or without the indicated factors.
At the indicated time, the culture medium was harvested and secreted protein
was analyzed either by precipitation with trichloroacetic acid (TCA) followed by
SDS-PAGE and immunoblotting, or by Hh reporter assays.
Reporter Assays
Hh activity was assayed in Shh Light II cells (Taipale et al., 2000). After incuba-
tion for 30 hr, firefly luciferase (expressed under control of a Hh-responsive
promoter) and Renilla luciferase (expressed under control of a constitutive
promoter) were measured using the Dual-Glo kit (Promega). Hh pathway
activity was calculated as the firefly/Renilla ratio, normalized to one for unsti-
mulated cells. Each experiment was performed in triplicate, and error bars
represent the SD of the mean. For coculture assays, 293T cells or DispA/
MEFs expressing various hShh, DispA, and Scube2 constructs were plated
together with Shh Light II cells. After 12 hr, the serum was washed off and
the cells were incubated for 30 hr in serum-free media, followed by luciferase
reporter assays.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2012.07.010.
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